Compared with baseline, at 1 month the losartan group had lower sitting SBP (2p = 0.042) and a higher LVM (2p = 0.028).(Table 3) However, there was no change in LVMI and this is presumably due to the change in weight between these time points although this did not reach statistical significance [median 74.2 (71.4–88.3) kg vs median 80.8 (74–90.4), 2p = 0.07].
← all excerpts
Can losartan and blood pressure control peri arteriovenous fistula creation ameliorate the early associated left ventricular hypertrophic response a randomised placebo controlled trial.
1
—
—